Company intelligence / Profile preview
Zhejiang Cuize Pharmaceutical Technology
Hangzhou, Zhejiang, Chinaxjpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Zhejiang Cuize Pharmaceutical Technology is a high-tech pharmaceutical R&D company specializing in respiratory medicine technology and complex preparation medicine technology. Its lead asset CZ1S is a small molecule drug currently in Phase 2 clinical trials targeting postoperative pain management after hemorrhoidectomy. The company focuses on developing innovative inhalation preparations and complex formulations with an emphasis on unmet needs in pain management and related therapeutic areas. No published late-stage or commercial results are available.
- Therapeutic areas
- GastroenterologyNeurology
- Modalities
- Small molecule drug
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Zhejiang Cuize Pharmaceutical Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhejiang Cuize Pharmaceutical Technology.